Pricing Log in Create free account

BeOne Medicines Ltd. - Sponsored ADR (ONC) vs Vertex Pharmaceuticals Incorporated (VRTX)

BeOne Medicines Ltd. - Sponsored ADR and Vertex Pharmaceuticals Incorporated are both Biotechnology companies. Vertex Pharmaceuticals Incorporated is the larger, with a market value of $129.0B against $39.0B — 3.3× the size. Vertex Pharmaceuticals Incorporated trades at the lower P/E: 28.8× against 62.6×. BeOne Medicines Ltd. - Sponsored ADR grew revenue faster over the last twelve months: 34.4% against 10.2%. Vertex Pharmaceuticals Incorporated has the higher net margin (35.0% vs 10.7%) and the lower return on invested capital (24.1% vs 60.2%). Across the 22 metrics below, Vertex Pharmaceuticals Incorporated leads on 12 and BeOne Medicines Ltd. - Sponsored ADR on 10.

Valuation

Metric ONC VRTX Biotechnology median
P/E 62.55 28.82 8.50
P/S 6.72 10.07 9.71
P/B 7.96 6.26 2.13
Price to free cash flow 31.43 33.38 20.82
EV/EBITDA 34.59 23.85 0.64
EV/Sales 6.08 9.47 9.21
Earnings yield 1.60% 3.47% (33.15%)
Free cash flow yield 3.18% 3.00% (25.50%)

Profitability

Metric ONC VRTX Biotechnology median
Gross margin 88.89% 86.00% 65.16%
Operating margin 15.06% 37.95% 0.00%
Net margin 10.70% 35.00% 0.00%
Free cash flow margin 21.70% 30.16% 0.00%
Return on equity 14.66% 23.54% (56.36%)
Return on assets 8.47% 17.12% (48.04%)
Return on invested capital 60.22% 24.09% 0.00%

Growth

Metric ONC VRTX Biotechnology median
Revenue growth (TTM) 34.35% 10.23% 6.02%
EPS growth (last fiscal year) 141.34% 836.54% 30.26%
Revenue growth, 5-year CAGR 76.85% 14.10% 9.41%
Net income growth, 5-year CAGR 0.00% 7.83% 0.00%

Health

Metric ONC VRTX Biotechnology median
Debt to equity 0.17 0.00 0.00
Current ratio 3.41 3.19 4.72
Net debt to EBITDA (6.09) (1.51) 0.96

Dividend

Metric ONC VRTX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ONC VRTX Biotechnology median
Market cap 39.01b 128.95b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack